248.97
Labcorp Holdings Inc (LH) 最新ニュース
Labcorp Adds New Tests for Solid Tumors, Hematologic Malignancies - marketscreener.com
Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research - marketscreener.com
Labcorp (LH) Expands Precision Oncology Portfolio with New Offerings | LH Stock News - GuruFocus
Labcorp Revolutionizes Cancer Care: New Test Portfolio Promises Faster Treatment Decisions - Stock Titan
Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report? - Yahoo Finance
Are Investors Undervaluing Labcorp (LH) Right Now? - Yahoo Finance
Labcorp Holdings Stock Outlook: Is Wall Street Bullish or Bearish? - MSN
Labcorp Holdings Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Should You Buy Labcorp Holdings Inc. (NYSE:LH) For Its Upcoming Dividend? - Yahoo
Labcorp (LH) Secures $117.03M Contract Modification for Laborato - GuruFocus
Chart of the Day: LabCorp Isn't Passing the Growth Test Yet - TheStreet Pro
Mizuho lifts LabCorp stock target to $274, keeps Outperform rating By Investing.com - Investing.com Canada
Labcorp Holdings (NYSE:LH) Partners With Frame to Enhance Fertility Testing Access - Yahoo Finance
Mizuho lifts LabCorp stock target to $274, keeps Outperform rating - Investing.com
Mizuho Adjusts Price Target on Labcorp Holdings to $274 From $264, Maintains Outperform Rating - marketscreener.com
Labcorp Holdings Inc. (LH) Announces Approval of 2025 Incentive and Stock Purchase Plans - GuruFocus
Labcorp shareholders approve new incentive plans By Investing.com - Investing.com Nigeria
Labcorp Holdings Approves Key Proposals at Annual Meeting - TipRanks
Labcorp shareholders approve new incentive plans - Investing.com
Here's Why Labcorp (LH) is a Strong Value Stock - Yahoo Finance
Baird Adjusts Price Target on Labcorp Holdings to $268 From $267, Maintains Outperform Rating - marketscreener.com
Here's Why Labcorp (LH) is a Strong Momentum Stock - Yahoo Finance
Global Preeclampsia Diagnostics Market to Exhibit Growth at a CAGR of ~4% by 2032 | DelveInsight - GlobeNewswire Inc.
Zacks Industry Outlook Highlights Cardinal Health, Labcorp And Align Technology - Barchart.com
Zacks Industry Outlook Highlights Cardinal Health, Labcorp and Align Technology - Yahoo Finance
Labcorp Holdings CEO Adam Schechter sells $1.52 million in stock By Investing.com - Investing.com South Africa
Labcorp Holdings CEO Adam Schechter sells $1.52 million in stock - Investing.com Australia
Insider Sell: Adam Schechter Sells Shares of Labcorp Holdings In - GuruFocus
Insider Sell: Adam Schechter Sells Shares of Labcorp Holdings Inc (LH) - GuruFocus
Labcorp Holdings Insider Sold Shares Worth $1,518,497, According to a Recent SEC Filing - marketscreener.com
LH Q1 Earnings Call: Labcorp Grows Revenue but Misses Expectations, Raises Adjusted EPS Guidance - Yahoo Finance
Labcorp Holdings (LH) Price Target Raised by Truist Securities | - GuruFocus
Labcorp (LH) Price Target Raised by Truist Analyst to $290 | LH Stock News - GuruFocus
Labcorp to Webcast Its Annual Meeting of Shareholders May 15 - The Malaysian Reserve
LabCorp Holdings Inc. (LH) Files Form 8-K with SEC - GuruFocus
Labcorp Holdings to Webcast Annual Shareholder Meeting - TipRanks
Justices' Labcorp Questions Explore Class Cert. Tensions - Law360
Labcorp Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72 - Yahoo Finance
Most Shareholders Will Probably Agree With Labcorp Holdings Inc.'s (NYSE:LH) CEO Compensation - simplywall.st
Labcorp Holdings' (NYSE:LH) Earnings May Just Be The Starting Point - Yahoo Finance
How A Labcorp Ruling Could Affect Wage Class Actions - Law360
Labcorp Holdings (LH) Price Target Raised by Piper Sandler | LH Stock News - GuruFocus
Analyst Expectations For Labcorp Hldgs's Future - Benzinga
Piper Sandler Adjusts Labcorp Holdings Price Target to $280 From $260, Maintains Neutral Rating - marketscreener.com
Labcorp case at Supreme Court could set precedent for class-action lawsuits - The Business Journals
Labcorp (LH) Receives Price Target Boost from Piper Sandler | LH Stock News - GuruFocus
大文字化:
|
ボリューム (24 時間):